Search results
Thousands to get cutting-edge personalised cancer vaccines in NHS trials
Daily Express· 5 days agoA cancer vaccine revolution will see thousands of NHS patients receive cutting-edge treatments...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 5 days agoSo he signed up to a trial of an investigational vaccine made by German pharma company BioNTech,...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 4 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
WGRZ-TV Buffalo· 2 days agoGovernment officials still say the benefits of the shots outweigh the risks. Health officials have...
Moderna's RSV Vaccine Approved by FDA
Medscape· 2 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 2 days agoFirst, its RSV vaccine wasn't linked to any cases of Guillain-Barré syndrome in late-stage clinical trials (the Pfizer and GSK vaccines
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 4 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
Moderna's RSV vaccine for older adults approved
Axios· 4 days agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 4 days agoThere are already two approved vaccines for those aged 60 and over, by GSK and Pfizer, both of which have been on the market since last year. "The FDA...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock | The Motley Fool
The Motley Fool· 6 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (PFE -1.70%) and AstraZeneca (AZN...
